Sun’s Caraco Unit To Close US Factory Despite FDA Clearance
This article was originally published in PharmAsia News
Executive Summary
A U.S. plant owned by Caraco Pharmaceutical Laboratories, a unit of India’s Sun Pharmaceuticals Industries, is set to be closed instead of resuming production that was halted by the U.S. FDA in 2009.
A U.S. plant owned by Caraco Pharmaceutical Laboratories, a unit of India’s Sun Pharmaceuticals Industries, is set to be closed instead of resuming production that was halted by the U.S. FDA in 2009. The agency cleared it to resume production of three drug products nearly two years ago, but Caraco never starting manufacturing these. The facility is located in Detroit, one of three plants in the area involved in the FDA's order to stop production. Before the order, Caraco, which Sun purchased in 1997, produced 35 generics and private-label drugs. (Click here for more)
"Caraco Pharmaceutical To Close Detroit Plant, Lay Off 178" - Detroit Free Press (U.S.) (4/30/2014)